Related Experiment Video
Updated: Dec 25, 2025

Genome Editing in Mammalian Cell Lines using CRISPR-Cas
Published on: April 11, 2019
A Cas12a ortholog with stringent PAM recognition followed by low off-target editing rates for genome editing
Peng Chen1, Jin Zhou1, Yibin Wan1
1State Key Laboratory of Virology, Hubei Key Laboratory of Cell Homeostasis, Department of Biochemistry and Molecular Biology, College of Life Sciences, Wuhan University, Wuhan, China.
Background:
AsCas12a and LbCas12a nucleases are reported to be promising tools for genome engineering with protospacer adjacent motif (PAM) TTTV as the optimal. However, the C-containing PAM (CTTV, TCTV, TTCV, etc.) recognition by Cas12a might induce extra off-target edits at these non-canonical PAM sites.
Results:
Here, we identify a novel Cas12a nuclease CeCas12a from Coprococcus eutactus, which is a programmable nuclease with genome-editing efficiencies comparable to AsCas12a and LbCas12a in human cells. Moreover, CeCas12a is revealed to be more stringent for PAM recognition in vitro and in vivo followed by very low off-target editing rates in cells. Notably, CeCas12a renders less off-target edits located at C-containing PAM at multiple sites compared to LbCas12a and AsCas12a, as assessed by targeted sequencing methods.
Conclusions:
Our study shows that CeCas12a nuclease is active in human cells and the stringency of PAM recognition could be an important factor shaping off-target editing in gene editing. Thus, CeCas12a provides a promising candidate with distinctive characteristics for research and therapeutic applications.
Insights
A new Cas12a enzyme, CeCas12a, offers precise genome editing in human cells. It exhibits high efficiency and reduced off-target edits, especially at non-canonical PAM sites, making it a promising tool for gene editing applications.
Area of Science:
- Molecular Biology
- Genetics
- Biotechnology
Background:
- Cas12a nucleases (AsCas12a, LbCas12a) are key genome engineering tools.
- Optimal protospacer adjacent motif (PAM) is TTTV, but C-containing PAMs cause off-target edits.
Purpose of the Study:
- Identify and characterize a novel Cas12a nuclease with improved specificity.
- Evaluate CeCas12a's genome editing efficiency and off-target profile in human cells.
Main Methods:
- Identification of CeCas12a from Coprococcus eutactus.
- Assessed genome editing efficiency and PAM recognition stringency in vitro and in vivo.
- Utilized targeted sequencing to evaluate off-target edits at canonical and non-canonical PAM sites.
Main Results:
- CeCas12a demonstrates genome editing efficiencies comparable to AsCas12a and LbCas12a in human cells.
- CeCas12a exhibits stringent PAM recognition, leading to significantly lower off-target edits.
- Reduced off-target edits were observed at C-containing PAM sites compared to LbCas12a and AsCas12a.
Conclusions:
- CeCas12a is an active nuclease in human cells with enhanced specificity.
- PAM recognition stringency is crucial for minimizing off-target edits in gene editing.
- CeCas12a presents a valuable tool for research and therapeutic gene editing applications.
Related Concept Videos
CRISPR/Cas9 Genome Editing
CRISPR
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Homologous Recombination
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...

